六月FDA密集批准多款IVD产品,涉及传染病检测、数字病理软件等领域,反映了行业技术迭代加速和临床需求多元化。罗氏、雅培等公司在传染病检测领域展现新成果,巩固了各自市场地位。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.